Raynier Devillier

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

Cristina Toffalori, Laura Zito, Valentina Gambacorta et al. · Nature Medicine · 2019 · 393 citations · Full text

Hematological Malignancy, Immune Signature, Transplantation +12

Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing

Sumin Jo, Shipra Das, Alan F. Williams et al. · Nature Communications · 2022 · 142 citations · Full text

Haploidentical T Cell–Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen–Matched Related or Unrelated Donor

Didier Blaise, Sabine Fürst, Roberto Crocchiolo et al. · Biology of Blood and Marrow Transplantation · 2015 · 88 citations · Full text

Role of<i>ASXL1</i>and<i>TP53</i>mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes

Raynier Devillier, Véronique Mansat‐De Mas, Véronique Gelsi‐Boyer et al. · Oncotarget · 2015 · 77 citations · Full text

Mixed-phenotype Acute Leukemia, Genetics, Pathology +16

The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT

Raynier Devillier, Roberto Crocchiolo, Luca Castagna et al. · Bone Marrow Transplantation · 2012 · 70 citations

Hematological Malignancy, Chronic Gvhd, Medicine +9